Showing results (431-440 of 8,779) with videos related to

Sort By:
Pageof 878
Pediatric Blood & Cancer|April 24, 2020
Regional differences in access to hematopoietic stem cell transplantation among pediatric patients with acute myeloid leukemiaTony H Truong, Jason D Pole, Henrique Bittencourt, et al.
Pediatric Blood & Cancer|April 24, 2020
Nationwide study of pediatric B-cell precursor acute lymphoblastic leukemia with chromosome 8q24/MYC rearrangement in JapanKimiyoshi Sakaguchi, Toshihiko Imamura, Sae Ishimaru, et al.
Pediatric Blood & Cancer|September 14, 2021
Pediatric cancer care in Africa: SIOP Global Mapping Program report on economic and population indicatorsJennifer Ann Geel, Julia Challinor, Neil Ranasinghe, et al.
Pediatric Blood & Cancer|September 14, 2021
Childhood cancer hospital resource utilization and costs in Egypt, 2013-2017; patterns, trends, and associated factors for 8886 patients from Children's Cancer Hospital, EgyptRanin Soliman, Alaa Elhaddad, Jason Oke, et al.
Pediatric Blood & Cancer|September 14, 2021
Efficacy and safety of ruxolitinib in ineffective erythropoiesis suppression as a pretransplantation treatment for pediatric patients with beta-thalassemia majorGalina Ovsyannikova, Dmitry Balashov, Irina Demina, et al.
Pediatric Blood & Cancer|July 17, 2015
Chemotherapy responsiveness in a patient with multiply relapsed ameloblastic fibro-odontosarcoma of the maxillaSusanne A Gatz, Khin Thway, Henry Mandeville, et al.
Pediatric Blood & Cancer|July 17, 2015
Adherence to prompt fever evaluation in children with sickle cell disease and the health belief modelCorinna L Schultz, Trudy Tchume-Johnson, Marilyn M Schapira, et al.
Pediatric Blood & Cancer|July 17, 2015
Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective StudyDeepak Chellapandian, Furqan Shaikh, Cor van den Bos, et al.
Pediatric Blood & Cancer|August 29, 2025
Two Cases of Juvenile Myelomonocytic Leukemia With Identical Somatic PTPN11 Mutations in Children After In Utero Exposure to Thiopurine-Containing ChemotherapyMarek Ussowicz, Monika Rosa, Monika Biedroń, et al.
Pediatric Blood & Cancer|August 29, 2025
Outcomes for Patients Aged 12-18 Months With Metastatic MYCN Non-Amplified Neuroblastoma and Unfavorable Biologic Features ("Mixed Biology Toddlers"): A Report From the International Neuroblastoma Risk Group (INRG) ProjectMallory R Taylor, James R Anderson, Julie R Park, et al.
Pageof 878